Newly observed thalamic involvement and mutations of the HEXA gene in a Korean patient with juvenile GM2 gangliosidosis

Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A (1991) Seven novel mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11:124–134 Beck M, Sieber N, Goebel HH (1998) Progressive cerebellar ataxia in juvenile GM2-gangliosidosis type Sandhoff. Eur J Pediatr 157(10):866–867 Conzelmann E, Kytzia HJ, Navon R, Sandhoff K (1983) Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet 35(5):900–913 Fernandes Filho JA, Shapiro BE (2004) Tay–Sachs disease. Arch Neurol 61(9):1466–1468 Frey LC, Ringel SP, Filley CM (2005) The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. Arch Neurol 62(6):989–994 Jun Fukumizu M, Yoshikawa H, Takashima S, Sakuragawa N, Kurokawa T (1992) Tay–Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 34(6):483–486 Gravel R, Kaback M, Proia R, Sandhoff K, Suzuki K (2001) The GM2 gangliosidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. 8th edn. McGraw-Hill, New York, NY, pp 3827–3876 Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Ballestri P (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250(1):17–21 Hund E, Grau A, Fogel W, Forsting M, Cantz M, Kustermann-Kuhn B, Harzer K, Navon R, Goebel HH, Meinck HM (1997) Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 145(1):25–31 Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O (2005) MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. Am J Neuroradiol 26(8):2037–2042 Kaback MM (2000) Population-based genetic screening for reproductive counseling: the Tay–Sachs disease model. Eur J Pediatr 159(Suppl 3):S192–S195 Kaback MM, Zeiger RS, Reynolds LW, Sonneborn M (1974) Approaches to the control and prevention of Tay–Sachs disease. Prog Med Genet 10:103–134 Kamatani N, Hakoda M, Otsuka S, Yoshikawa H, Kashiwazaki S (1992) Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J Clin Invest 90(1):130–135 Maegawa GH, Stockley T, Tropak M, Banwell B, Blaser S, Kok F, Giugliani R, Mahuran D, Clarke JT (2006) The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 118(5):e1550–e1562 Epub 2006 Oct 2 Montalvo AL, Filocamo M, Vlahovicek K, Dardis A, Lualdi S, Corsolini F, Bembi B, Pittis MG (2005) Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay–Sachs disease: detection of fourteen novel alleles. Human Mutat 26(3):1–9 Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K (1996) MR findings in Tay–Sachs disease. J Comput Assist Tomogr 20(4):551–555 Myerowitz R, Costigan FC (1988) The major defect in Ashkenazi Jews with Tay–Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. J Biol Chem 263(35):18587–18589 Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH (2005) Late-onset Tay–Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7(2):119–123 Ozkara HA, Navon R (1998) At least six different mutations in HEXA gene cause Tay–Sachs disease among the Turkish population. Mol Genet Metab 65(3):250–253 Paw BH, Kaback MM, Neufeld EF (1989) Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Proc Natl Acad Sci USA 86(7):2413–2417 (Erratum in: Proc Natl Acad Sci USA 86(14):5625) Specola N, Vanier MT, Goutieres F, Mikol J, Aicardi J (1990) The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology 40(1):145–150 Streifler JY, Gornish M, Hadar H, Gadoth N (1993) Brain imaging in late-onset GM2 gangliosidosis. Neurology 43(10):2055–2058 Sutton VR (2002) Tay–Sachs disease screening and counseling families at risk for metabolic disease. Obstet Gynecol Clin North Am 29(2):287–296 Triggs-Raine BL, Feigenbaum AS, Natowicz M, Skomorowski MA, Schuster SM, Clarke JT, Mahuran DJ, Kolodny EH, Gravel RA (1990) Screening for carriers of Tay–Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med 323(1):6–12